Ihab Doss, MD
Interventional Pain Medicine · Warrensburg, MONPI 1124006085
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,845 of the $6,477 with a category attached, or 74.8%. 10 manufacturers reported payments, led by Stryker at 54.3% of the total. Reporting peaked in 2019 at $2,855 and has fallen 61.5% since, to $1,099 in 2025.
Across 52 payments — averaging $124.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Vertiflex, Inc.$2K
- Medtronic$399
- Spinal Simplicity, LLC$96
- SPR Therapeutics, Inc$94
- Boston Scientific$50
- plus $73 from 4 others
What the payments were for
- Travel & lodging$4,84575%
- Food & beverage$1,63125%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 23 | $3,516 |
| Vertiflex, Inc. | 10 | $2,248 |
| Medtronic(2 entities) | 6 | $399 |
| Spinal Simplicity, LLC | 2 | $96 |
| SPR Therapeutics, Inc | 5 | $94 |
| Boston Scientific | 2 | $50 |
| Merck | 1 | $22 |
| Abbott | 1 | $18 |
| Saluda Medical Americas, Inc. | 1 | $18 |
| Novo Nordisk | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion ISS$2,051
- SPINEJACK$1,908
- mild Device Kit$990
- IVS - VERTEBRAL AUGMENTATION PRODUCTS$238
- INTELLIS$166
- RESTORE$132
How this compares
$6,477 in reported general payments places this provider in the 60th percentile of 27 interventional pain medicine providers in Missouri.
See all interventional pain medicine providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tizanidine Hcl | 449 | $5,043 |
| Gabapentin | 410 | $3,324 |
| Duloxetine Hcl | 83 | $1,914 |
| Tramadol Hcl | 218 | $672 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 56 | $429 |
| Cyclobenzaprine Hcl | 28 | $197 |
| Methylprednisolone | 12 | $108 |
| Meloxicam | 49 | $72 |
| Amitriptyline Hcl | 13 | $63 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Warrensburg
- Rebecca SandersJoplin$209K
- Ramis GheithBridgeton$73K
- Helen BlakeChesterfield$48K
- Andrew FrazierKansas City$32K
- Christian OliverBridgeton$18K
- David TonkinSpringfield$14K
- Dwayne JonesKansas City$11K
- Bradford NobleColumbia$8K
- Calvin CajigalDes Peres$8K
- James NewtonColumbia$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.